Nephrocare Health Services Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Nephrocare Health Services Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Profit Cash Ratio: Over the last 3 years, every ₹100 of reported profit came with ₹246 of operating cash. Higher than 91% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹246Over the last 3 years, every ₹100 of reported profit came with ₹246 of operating cash.
Higher than 91% of Healthcare companies in India.
Self-Funding Ratio
1.5×Over the last 3 years its own operating cash covered its investment spending (capex) 1.5 times.
Higher than 56% of Healthcare companies in India.
Cash Locked Ratio
₹16For every ₹100 of sales, ₹16 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹32 tied up three years earlier.
Less money tied up than 66% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 83% of Healthcare companies in India.
Growth Efficiency Ratio
₹15Sales grew 140% in 3 years; of every extra ₹100 of sales, ₹15 became extra profit.
Lower than 54% of Healthcare companies in India.
Asset Productivity Ratio
+140% / +121%In 3 years sales changed by +140% while total assets changed by +121%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
10.1×Debt due within a year is covered 10.1 times by its yearly operating cash.
Higher than 77% of Healthcare companies in India.
Cash Cushion Ratio
+6%Cash, after subtracting all debt, equals 6% of its market value (net cash).
Higher than 84% of Healthcare companies in India.
Tangible Assets Ratio
92%Of every ₹100 the company owns, ₹92 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 66% of Healthcare companies in India.
Tangible Net Worth Ratio
89%Of every ₹100 of net worth, ₹89 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 62% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Nephrocare Health Services Limited owes ₹0.24 for every ₹1 it owns. Net profit rose 15% in the year to Mar 2026.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
70.3Investors pay ₹70.3 for every ₹1 of Nephrocare Health Services Limited's yearly profit, higher than 82% of Healthcare companies in India.
P/B ratio
5.37The share price is 5.37 times Nephrocare Health Services Limited's book value per share, higher than 59% of Healthcare companies in India.
Market cap
₹5,998 CrThe total market value of all of Nephrocare Health Services Limited's shares at today's price (share price × number of shares), larger than 52% of Healthcare companies in India. PosiCap size class: Mini Cap.
Net worth (book value)
₹1,116 CrWhat Nephrocare Health Services Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹111.03Net worth divided by the number of shares. The share price of ₹596.45 is 5.4 times this, which is the P/B above.
Return on equity (ROE)
7.6%Nephrocare Health Services Limited earned 7.6% on its shareholders' money over the last year, lower than 75% of Healthcare companies in India.
Owes vs Owns
0.24×Nephrocare Health Services Limited owes ₹0.24 for every ₹1 it owns (low), lower than 75% of Healthcare companies in India.
Dividend yield
NoneNephrocare Health Services Limited does not currently pay a dividend.
Revenue growth
+33%Revenue rose 33% in the year to Mar 2026, and grew 34% a year on average over 3 years.
Profit growth
+15%Net profit rose 15% in the year to Mar 2026.
Profit margin
7.7%Nephrocare Health Services Limited keeps ₹8 of every ₹100 of revenue as net profit.
Cash quality
3.0×Cash from Nephrocare Health Services Limited's business was 3.0× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
2.4×Nephrocare Health Services Limited's operating profit covered its interest costs 2.4 times in the year to Mar 2026.
Cash vs debt
Net cashNephrocare Health Services Limited held ₹377 Cr more cash than debt (net cash) at Mar 2026.
Questions
What is Nephrocare Health Services Limited's P/E ratio?
Investors pay ₹70.3 for every ₹1 of Nephrocare Health Services Limited's yearly profit, higher than 82% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Nephrocare Health Services Limited: ₹5,998 Cr ÷ ₹1,116 Cr (31 Mar 2026) = 5.4.
What is Nephrocare Health Services Limited's return on equity?
Nephrocare Health Services Limited earned 7.6% on its shareholders' money over the last year, lower than 75% of Healthcare companies in India.
How much does Nephrocare Health Services Limited owe compared with what it owns?
Nephrocare Health Services Limited owes ₹0.24 for every ₹1 it owns (low), lower than 75% of Healthcare companies in India.
Does Nephrocare Health Services Limited pay a dividend?
No. Nephrocare Health Services Limited does not currently pay a dividend.
Is Nephrocare Health Services Limited's revenue growing?
Revenue rose 33% in the year to Mar 2026, and grew 34% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.